Deliberative processes in health technology assessment of medicines: the case of Spain.

ABSTRACT:

Objectives

Spain incorporated in 2020 changes in its health technology assessment (HTA), pricing, and reimbursement system for medicines including publishing reports, development of networks of experts, or consultation with stakeholders. Despite these changes, it is unclear how deliberative frameworks are applied and the process has been criticized for not being sufficiently transparent. This study analyses the level of implementation of deliberative processes in HTA for medicines in Spain.

Methods

We review the grey literature and summarize the Spanish HTA, pricing, and reimbursement process of medicines. We apply the deliberative processes for HTA checklist, developed to assess the overall context of the deliberative process, and identify the stakeholders involved and type

SUBMITTER: Pinilla-Dominguez P 

PROVIDER: S-EPMC11569961 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature